Consider Patient Factors Before Determining RCC Treatment
While cytoreductive nephrectomy has been a mainstay in kidney cancer treatment, there are factors to consider before using the procedure on patients with the disease.
Related Articles
Atebimetinib Combo Shows Survival Signal in First-Line Pancreatic Cancer
The novel MEK inhibitor atebimetinib plus chemo showed early signs of survival benefit in first-line treatment of patients with pancreatic cancer.
Subcutaneous Daratumumab Could Mark First Smoldering Myeloma Treatment
Per ODAC and CHMP recommendations, subcutaneous daratumumab may become the first approved treatment for smoldering myeloma. Here’s what nurses should know.
BCI, Patient Preference Guide Nurses in 5-Year Endocrine Counseling
The BCI and patient goals help oncology nurses counsel patients on endocrine therapy use after 5 years, per Michelle Kirschner RN, MSN, ACNP, APRN-BC.
Anemia Protocol Does Not Reduce Ruxolitinib Efficacy in Myelofibrosis
Adding danazol or erythropoiesis-stimulating agents for anemia management to a ruxolitinib regimen for myelofibrosis does not decrease treatment efficacy.
Rx Road Map: Durvalumab for Non-Small Cell Lung Cancer
Read Stacey Hield, BSN, RN, OCN’s recommendations for best use of durvalumab in non-small cell lung cancer.
Genomic Changes May Drive Sotorasib KRAS G12C+ Combo Resistance in CRC
Biomarker data from CodeBreaK 300 suggest DNA and RTK pathway alterations may underlie resistance to sotorasib plus panitumumab in CRC.
FDA Approves Tafasitamab Combo for R/R Follicular Lymphoma
The FDA has approved tafasitamab in combination with lenalidomide and rituximab for adults with relapsed/refractory follicular lymphoma.
CDK4/6 Inhibition Customizes Frontline HR+, HER2- mBC Treatment
According to Kimberly Podsada, BSN, RN, MSN, NP-C, CNS, the availability of 3 CDK4/6 inhibitors in first-line mBC therapy gives patients more choices.
No One Should Face Cancer Alone: The Power of Community in Cancer Care
Ask patients, “Who’s in your corner?”
Nurses’ Role in Grief Support for Pediatric Brain Cancer Survival
Oncology nurses can help patients and families understand the expectations of pediatric brain cancer survival, says Kasey Rangan, MSN, CPNP-PC, CPHON.